Clinical Trials for Cutaneous Squamous Cell Carcinoma of the Head and Neck

Find clinical trials for cutaneous squamous cell carcinoma of the head and neck. Discover research opportunities and treatment options in your area.

5 Active Trials Found

Showing 5 trials on this page

Page 1 of 1

Phase 2 Pragmatic Trial of Sentinel Lymph Node Biopsy (SLNB) in Patients With Clinically Node-Negative (cN0), High-Risk Cutaneous Squamous Cell Carcinoma (cSCC) of the Head and Neck

NCT ID: NCT06990737

This clinical trial is looking at a procedure called Sentinel Lymph Node Biopsy (SLNB) for patients with a specific type of skin cancer known as cutaneous squamous cell carcinoma (cSCC) that has no...

Not yet recruiting

Phase: PHASE2 Type: interventional Locations: Sacramento, California, United States

Towards Cure Via Only Ultra-short ICB in CSCC

NCT ID: NCT06823479

This clinical trial, titled "Towards Cure Via Only Ultra-short ICB in CSCC," is exploring whether patients with cutaneous squamous cell carcinoma (CSCC) can be treated effectively using only immuno...

Recruiting

Phase: PHASE2 Type: interventional Locations: Utrecht, , Netherlands, Maastricht, Limburg, Netherlands +3 more

Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation

NCT ID: NCT06662058

This clinical trial is looking at how offering hearing tests close to home or through remote options can help monitor hearing loss in patients with certain types of head and neck cancers who are re...

Recruiting

Phase: NA Type: interventional Locations: Atlanta, Georgia, United States

Intensity Modulated Proton or X-Ray Therapy After Surgery for Treatment of Head and Neck Cancer, the HEADLIGHT Study

NCT ID: NCT05075980

The HEADLIGHT study is a clinical trial that looks at two types of radiation therapy—intensity modulated proton therapy (IMPT) and intensity modulated X-ray therapy (IMRT)—to see how well they work...

Recruiting

Phase: PHASE2 Type: interventional Locations: Scottsdale, Arizona, United States, Scottsdale, Arizona, United States +8 more

Neoadjuvant Pembrolizumab in Cutaneous Squamous Cell Carcinoma

NCT ID: NCT05025813

This clinical trial is studying the use of a medication called Pembrolizumab for patients with a type of skin cancer known as cutaneous squamous cell carcinoma (cSCC) located on the head and neck. ...

Recruiting

Phase: PHASE2 Type: interventional Locations: Herston, Queensland, Australia, Woolloongabba, Queensland, Australia +1 more

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions